BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21647008)

  • 1. Chemotherapy induced nausea and vomiting: a European perspective.
    Vidall C
    Br J Nurs; 2011 May 27-Jun 9; 20(10):S22, S25-8. PubMed ID: 21647008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relieving nausea and vomiting in patients with cancer: a treatment algorithm.
    Johnson MH; Moroney CE; Gay CF
    Oncol Nurs Forum; 1997; 24(1):51-7. PubMed ID: 9007907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating aprepitant and palonosetron into clinical practice: a role for the new antiemetics.
    Viale PH
    Clin J Oncol Nurs; 2005 Feb; 9(1):77-84. PubMed ID: 15751501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
    Viale PH; Grande C; Moore S
    Clin J Oncol Nurs; 2012 Aug; 16(4):E133-41. PubMed ID: 22842698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R
    Oncol Nurs Forum; 1989; 16(4):563-74. PubMed ID: 2666957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey.
    Dielenseger P; Börjeson S; Vidall C; Young A; Jahn P
    Support Care Cancer; 2019 Nov; 27(11):4099-4106. PubMed ID: 30783815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myths of antiemetic administration.
    Peters CA
    Cancer Nurs; 1989 Apr; 12(2):102-6. PubMed ID: 2713833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
    Goodman M
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best practice management of CINV in oncology patients: II. Antiemetic guidelines and rationale for use.
    Wickham R
    J Support Oncol; 2010; 8(2 Suppl 1):10-5. PubMed ID: 20629453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic therapy in patients receiving cancer chemotherapy.
    Marek C
    Oncol Nurs Forum; 2003; 30(2):259-71. PubMed ID: 12692660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact and management of chemotherapy/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists/oncology nurses and patients: a cross-sectional multinational survey.
    Vidall C; Fernández-Ortega P; Cortinovis D; Jahn P; Amlani B; Scotté F
    Support Care Cancer; 2015 Nov; 23(11):3297-305. PubMed ID: 25953380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nurse's role in managing chemotherapy-induced nausea and vomiting: an international survey.
    Krishnasamy M; Kwok-Wei So W; Yates P; de Calvo LE; Annab R; Wisniewski T; Aranda S
    Cancer Nurs; 2014; 37(4):E27-35. PubMed ID: 24145248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.
    Trigg ME; Higa GM
    J Oncol Pharm Pract; 2010 Dec; 16(4):233-44. PubMed ID: 20085961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adjuvant doxorubicin and cyclophosphamide.
    Shih V; Wan HS; Chan A
    Ann Pharmacother; 2009 Mar; 43(3):444-52. PubMed ID: 19193584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical roundtable monograph. Treatment of chemotherapy-induced nausea and vomiting: a post-MASCC 2010 discussion.
    Kris MG; Urba SG; Schwartzberg LS
    Clin Adv Hematol Oncol; 2011 Jan; 9(1):suppl 1-15. PubMed ID: 21370520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to antiemetic guidelines and control of chemotherapy-induced nausea and vomiting (CINV) in a large hospital.
    Caracuel F; Muñoz N; Baños U; Ramirez G
    J Oncol Pharm Pract; 2015 Jun; 21(3):163-9. PubMed ID: 24598374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
    Oo TH; Hesketh PJ
    Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.